Company intelligence / Profile preview

Arcadia Biosciences

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Arcadia Biosciences is focused on developing agricultural traits and branded consumer food ingredients, with its main commercial product being the GoodWheat line of wheat varieties designed for improved health and nutrition; it pivoted away from trait licensing toward consumer-branded foods and reported revenues of $1.3 million in Q3 2024, reflecting ongoing commercialization efforts[1][2].

Industry: Agriculture & AgTech

Partnerships

Bioceres (joint venture: Verdeca, commercializing HB4 soybean technology)[4][2]

Beyond the preview

Go deeper on Arcadia Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcadia Biosciences.

Explore the full profile